← Open Payments lookup

RAYMOND KIMBALL: Open Payments

NPI 1285668608 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$984 in 41 payments from 10 companies in 2025. Trend: 2023 $306 · 2024 $670 · 2025 $984

Food & beverage: $984
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.9$263
Otsuka America Pharmaceutical, Inc.11$247
Teva Pharmaceuticals USA, Inc.8$207
Alkermes, Inc.3$69
Neurocrine BioSciences, Inc.2$45
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$41
Janssen Pharmaceuticals, Inc2$37
Vanda Pharmaceuticals Inc.2$31
Axsome Therapeutics, Inc.1$25
Lundbeck LLC1$19

Products named: COBENFY, ABILIFY MAINTENA, UZEDY, AUSTEDO XR, ABILIFY ASIMTUFII, REXULTI, INGREZZA, CAPLYTA.

Industry payments across SC — which companies pay providers there.